The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Crossref DOI link: https://doi.org/10.1007/s40487-016-0037-8
Published Online: 2017-01-03
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schey, Steve
Montero, Luis Felipe Casado
Stengel-Tosetti, Chloe
Gibson, Craig J.
Dhanasiri, Sujith
Funding for this research was provided by:
Celgene